
Pulse Biosciences Investor Relations Material
Latest events

Q1 2025
Pulse Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pulse Biosciences Inc
Access all reports
Pulse Biosciences Inc. is a medical technology company that develops therapeutic devices based on its proprietary Nano-Pulse Stimulation (NPS) technology. This technology uses short, nanosecond-duration electrical pulses to treat cellular structures, offering potential applications in dermatology, oncology, and other medical fields. Pulse Biosciences' products are designed to provide non-invasive treatment options, with the goal of improving clinical outcomes for patients in various therapeutic areas. The company is headquartered in Hayward, California, and its shares are listed on the NASDAQ.
Key slides for Pulse Biosciences Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pulse Biosciences Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pulse Biosciences Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
PLSE
Country
🇺🇸 United States